New panelist annoucement!
Greater Toronto Area Chapter
Annual General Meeting featuring Bill Charnetski
Ontario’s Chief Health Innovation Strategist: Catalyst for Collaboration and Commercialization
May 24, 2016
5:00 p.m. – 7:00 p.m.
BMO UHN Education and Conference Centre, Toronto Western Hospital
60 Leonard Ave, Toronto
Krembil entrance at corner of Leonard Ave and Nassau St, Toronto, ON
Keynote Speaker: William Charnetski, Chief Health Innovation Strategist for Ontario
- Lisa Purdy, Partner and National Leader, Health Services, Deloitte
- Mike Monteith, Co-founder and CEO @ ThoughtWire
- Andreas Laupacis, Executive Director, Li Ka Shing Knowledge Institute, St. Michael’s Hospital
Moderator: Rob Fox, Director of Healthcare Transformation, CISCO Systems
|| In addition to speaking to the OCHIS office purpose and priorities, Bill will be pleased to share exciting news regarding the launch of the Health Technologies Fund (HTF) and the hiring of Innovation Brokers.
These milestones represent important steps in implementing the recommendations made by the Ontario Health Innovation Council to drive collaboration across the health care system to accelerate the adoption and diffusion of new innovative health technologies and processes to:
- Improve patient outcomes (in accordance with the Ministry of Health and Long-Term Care’s Patients First: Action Plan for Health Care)
- Add value to the system
- Create jobs in Ontario
|Join us at the CCHL GTA Chapter’s AGM for a conversation with Ontario’s Chief Health Innovation Strategist. What is the secret to unlocking Ontario’s potential for innovation?
| CCHL Member
Mr. Charnetski is an accomplished national and global executive who has worked in the highest levels of business, law and government. He has a track record of leading transformational change, developing organizations, leading people to realize their potential, fostering internal and external partnerships and collaboration, and delivering results. He has spent more than 10 years working on integrated health solutions in Canada and around the world in the rapidly changing global pharmaceutical industry.
Mr. Charnetski most recently worked in the United Kingdom with AstraZeneca, one of the world's largest innovative pharmaceutical companies. He led the global government affairs and public policy function and had responsibilities for corporate social responsibility and regional communications. His team delivered tangible business results while enhancing health outcomes in many places around the world.